AptarGroup, Inc. (ATR)
- Previous Close
150.92 - Open
151.88 - Bid 151.74 x 800
- Ask 152.05 x 1000
- Day's Range
150.63 - 152.67 - 52 Week Range
130.85 - 178.03 - Volume
133,715 - Avg. Volume
381,883 - Market Cap (intraday)
10.056B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
27.89 - EPS (TTM)
5.46 - Earnings Date Jul 31, 2025
- Forward Dividend & Yield 1.80 (1.19%)
- Ex-Dividend Date May 1, 2025
- 1y Target Est
175.00
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
www.aptar.com13,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ATR
View More
Performance Overview: ATR
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATR
View MoreValuation Measures
Market Cap
9.97B
Enterprise Value
10.89B
Trailing P/E
27.59
Forward P/E
27.62
PEG Ratio (5yr expected)
4.68
Price/Sales (ttm)
2.87
Price/Book (mrq)
3.93
Enterprise Value/Revenue
3.06
Enterprise Value/EBITDA
13.93
Financial Highlights
Profitability and Income Statement
Profit Margin
10.41%
Return on Assets (ttm)
7.13%
Return on Equity (ttm)
15.05%
Revenue (ttm)
3.55B
Net Income Avi to Common (ttm)
370.24M
Diluted EPS (ttm)
5.46
Balance Sheet and Cash Flow
Total Cash (mrq)
136.82M
Total Debt/Equity (mrq)
42.11%
Levered Free Cash Flow (ttm)
314.39M
Research Analysis: ATR
View MoreResearch Reports: ATR
View MoreAptar Earnings: Growth in Pharma Offset by Currency Effects and Declines in Beauty and Closures
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
RatingPrice TargetRaising target price to $165.00
APTARGROUP INC has an Investment Rating of BUY; a target price of $165.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $160.00
APTARGROUP INC has an Investment Rating of BUY; a target price of $160.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $158.00
APTARGROUP INC has an Investment Rating of BUY; a target price of $158.000000; an Industry Subrating of High; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target